# Dario Amodei: AI Companies Have Failed to Deliver on Promises

Anthropic CEO admits the AI industry has not lived up to its big promises.

- **Source:** [The Next Web](https://brifing.si/source/afe24b20-b275-4c19-b9a6-8bb3c8babae7)
- **Published:** 2026-08-16
- **Topic:** [Data & AI](https://brifing.si/c/data-ai)
- **Original article:** <https://thenextweb.com/news/dario-amodei-ai-public-trust-cure-cancer-ipo>
- **On Brifing:** https://brifing.si/s/cd06aa16-1e45-43ee-b6cf-e9336258f182

## AI Companies' Promises

Dario Amodei acknowledged on X that AI companies, including Anthropic, have yet to deliver on their grand promises. He stated that the only way to win public trust is through genuine breakthroughs. This statement comes as Anthropic prepares for an IPO expected to value the company at $2 trillion.

## Public Trust Erosion

Amodei noted that promises like AI curing cancer have become clichés rather than inspiring, with many finding them deceptive. He emphasized that real achievements, such as actually curing cancer, are the only way to regain public trust.

## IPO and Valuation

Anthropic's IPO is set for October, with a valuation of $2 trillion. This valuation is based on what the technology could achieve in the future, not what it has accomplished so far. This highlights investor expectations and risks.

## Public Perception

According to Pew Research, half of American adults are more concerned than excited about AI in daily life. This is up from 37% in 2021. Only 10% are excited about AI. These figures underscore public distrust in AI.

## Corporate Responsibility

Amodei argued that public distrust in AI companies stems from decades of skepticism towards corporations in general. He stated that AI is just the latest iteration of this skepticism. This situation calls for companies to rethink their relationship with society.

## Are Breakthroughs Enough?

An OpenAI employee pointed out that the pharmaceutical industry constantly delivers advancements yet remains one of the least trusted sectors. People will judge AI companies not just on results but also on pricing, access, lobbying, and power distribution.

## Open Source Debate

Yann LeCun argued that the only way forward for AI is for it to be 'widely available, shared, and open.' This is a position Anthropic rejects for its frontier models, while Meta is pushing Washington in this direction. This debate is critical for the future of AI.

## Future Expectations

Amodei stated that Anthropic expects incredible results in the coming years and early glimmers in the coming months. These expectations allow the IPO to proceed ahead of these glimmers. The company's future hinges on whether these promises will be fulfilled.

## Sources covering this story

- https://thenextweb.com/news/dario-amodei-ai-public-trust-cure-cancer-ipo — 

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
